Baidu
map

康民国际医院获得Global Healthcare Accreditation认证

2017-11-16 佚名 MedSci原创

佛罗里达州棕榈滩花园2017年11月10日电 /美通社/ -- 自2002年起从事医疗旅游事业的开拓者康民国际医院(Bumrungrad International Hospital,简称“BIH”,网址:https://www.bumrungrad.com/thailandhospital )凭借其医疗目的地计划 (Medical Destination Program),荣获Global Healthcare Accreditation计划(网址:http://globalhealthcareaccreditation.com/ )的3年制“卓越认证”。

generated by system

作为东南亚一家最大的私立医院,康民国际医院为来自190多个国家的患者提供一整套三级医疗服务,以及30多个专业中心。CBS的《60分钟》(60 Minutes)、NBC的《今日秀》(Today Show)、《时代》(Time)、《新闻周刊》(Newsweek)和其它国际媒体均对康民国际医院进行了报道,将其视为医疗旅游的领导者。2002年,康民国际医院做出了以国际患者为目标的战略决策,并且当前50%以上的患者均为医疗旅游者。

在2017年10月2日于加州洛杉矶举行的第十届世界医疗旅游与全球健康大会(World Medical Tourism & Global Healthcare Congress)上,康民国际医院国际医疗主任埃里克-弗莱施曼(Erik Fleischman)博士接受了标志着该医院荣获GHA认证的牌匾。

弗莱施曼博士对此表示:“20多年来,康民国际医院一直是美国以外的国际医疗照护领域的领导者。我们于2002年成为了亚洲首家荣获Joint Commission International (JCI)(美国医疗机构评审联合委员会国际部)认证的医院,并且我们现在也是亚洲首家荣获Global Healthcare Accreditation (GHA)认证的医院。这些重要认证帮助我们成为国际医疗照护领域追求品质与临床卓越性的领导者,并且展现我们拥有比肩任何优秀西方医疗照护系统的优质照护服务。GHA特别适合我们医院,这是因为在帮助确保患者从出门到他们接受医疗照护之后回家的整段时间都获得优质照护服务方面,GHA是唯一的认证。我们是一所优秀的医院,在获得GHA认证之后,我们将更加优秀。”

Global Healthcare Accreditation (GHA)计划是一个独立的认证机构,致力于改善病人体验,以及在国内外旅游时接受医疗护理和治疗的病人所获得的良好照顾。

Global Healthcare Accreditation首席执行官凯伦-蒂蒙斯(Karen Timmons)表示:“进行旅游的患者与支付者日益要求获得高品质的患者体验。GHA努力确保患者能够积极参与,以及组织机构可以在医疗旅游照护连续统一体的各个接触点,主动地管理文化敏感性与交流。此外,GHA还对医疗旅游照护连续统一体进行优化,并且在验证医疗旅游的质量、增加透明度和实施可持续业务模式方面,为医疗提供者提供相关支持。对于康民国际医院致力于在管理医疗旅游者方面提供最佳实践,GHA表示赞赏,我们也期待将我们的良好合作延续到未来。”

康民国际医院简介:

康民国际医院是一家国际认可的多专科医院,位于泰国曼谷的核心地段。康民国际医院于1980年成立,并于1989年在泰国证交所(Stock Exchange of Thailand)上市,目前是东南亚最大的一所私立医院。康民国际医院每年为110万名患者提供服务,包括来自190个不同国家的50多万国际患者。

有意参加The Global Healthcare Accreditation计划的组织机构,可以通过以下方式提出请求,电邮:info@ghaccreditation.com | 电话:001-561-327-9557(美国)| 网址:www.GlobalHealthcareAccreditation.com

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1861178, encodeId=00a418611e896, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Aug 24 22:42:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941058, encodeId=40da19410581f, content=<a href='/topic/show?id=b1e74108e0b' target=_blank style='color:#2F92EE;'>#国际医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41087, encryptionId=b1e74108e0b, topicName=国际医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dba135, createdName=xuyong523, createdTime=Tue Dec 12 13:42:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685468, encodeId=5d9c168546826, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8544, encryptionId=2139854472, topicName=HCA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4a28195983, createdName=tsing_hit, createdTime=Sun Oct 07 23:42:00 CST 2018, time=2018-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325605, encodeId=82fc1325605f4, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581465, encodeId=2837158146590, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621686, encodeId=40c016216863b, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=)]
    2018-08-24 shizhenshan
  2. [GetPortalCommentsPageByObjectIdResponse(id=1861178, encodeId=00a418611e896, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Aug 24 22:42:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941058, encodeId=40da19410581f, content=<a href='/topic/show?id=b1e74108e0b' target=_blank style='color:#2F92EE;'>#国际医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41087, encryptionId=b1e74108e0b, topicName=国际医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dba135, createdName=xuyong523, createdTime=Tue Dec 12 13:42:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685468, encodeId=5d9c168546826, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8544, encryptionId=2139854472, topicName=HCA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4a28195983, createdName=tsing_hit, createdTime=Sun Oct 07 23:42:00 CST 2018, time=2018-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325605, encodeId=82fc1325605f4, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581465, encodeId=2837158146590, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621686, encodeId=40c016216863b, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1861178, encodeId=00a418611e896, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Aug 24 22:42:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941058, encodeId=40da19410581f, content=<a href='/topic/show?id=b1e74108e0b' target=_blank style='color:#2F92EE;'>#国际医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41087, encryptionId=b1e74108e0b, topicName=国际医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dba135, createdName=xuyong523, createdTime=Tue Dec 12 13:42:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685468, encodeId=5d9c168546826, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8544, encryptionId=2139854472, topicName=HCA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4a28195983, createdName=tsing_hit, createdTime=Sun Oct 07 23:42:00 CST 2018, time=2018-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325605, encodeId=82fc1325605f4, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581465, encodeId=2837158146590, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621686, encodeId=40c016216863b, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=)]
    2018-10-07 tsing_hit
  4. [GetPortalCommentsPageByObjectIdResponse(id=1861178, encodeId=00a418611e896, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Aug 24 22:42:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941058, encodeId=40da19410581f, content=<a href='/topic/show?id=b1e74108e0b' target=_blank style='color:#2F92EE;'>#国际医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41087, encryptionId=b1e74108e0b, topicName=国际医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dba135, createdName=xuyong523, createdTime=Tue Dec 12 13:42:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685468, encodeId=5d9c168546826, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8544, encryptionId=2139854472, topicName=HCA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4a28195983, createdName=tsing_hit, createdTime=Sun Oct 07 23:42:00 CST 2018, time=2018-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325605, encodeId=82fc1325605f4, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581465, encodeId=2837158146590, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621686, encodeId=40c016216863b, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1861178, encodeId=00a418611e896, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Aug 24 22:42:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941058, encodeId=40da19410581f, content=<a href='/topic/show?id=b1e74108e0b' target=_blank style='color:#2F92EE;'>#国际医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41087, encryptionId=b1e74108e0b, topicName=国际医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dba135, createdName=xuyong523, createdTime=Tue Dec 12 13:42:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685468, encodeId=5d9c168546826, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8544, encryptionId=2139854472, topicName=HCA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4a28195983, createdName=tsing_hit, createdTime=Sun Oct 07 23:42:00 CST 2018, time=2018-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325605, encodeId=82fc1325605f4, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581465, encodeId=2837158146590, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621686, encodeId=40c016216863b, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=)]
    2017-11-18 HinsMax
  6. [GetPortalCommentsPageByObjectIdResponse(id=1861178, encodeId=00a418611e896, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Aug 24 22:42:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941058, encodeId=40da19410581f, content=<a href='/topic/show?id=b1e74108e0b' target=_blank style='color:#2F92EE;'>#国际医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41087, encryptionId=b1e74108e0b, topicName=国际医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8dba135, createdName=xuyong523, createdTime=Tue Dec 12 13:42:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685468, encodeId=5d9c168546826, content=<a href='/topic/show?id=2139854472' target=_blank style='color:#2F92EE;'>#HCA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8544, encryptionId=2139854472, topicName=HCA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4a28195983, createdName=tsing_hit, createdTime=Sun Oct 07 23:42:00 CST 2018, time=2018-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325605, encodeId=82fc1325605f4, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581465, encodeId=2837158146590, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621686, encodeId=40c016216863b, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sat Nov 18 00:42:00 CST 2017, time=2017-11-18, status=1, ipAttribution=)]

相关资讯

十年 “走进西部”,拜耳全力支持中国基层医疗卫生服务

/* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li

春雨医生获评数字化转型颠覆者

/* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li

CAR-T市场呈指数增长,人类进入新的医学创新前沿

/* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; f

Baidu
map
Baidu
map
Baidu
map